The metabolism of this medicine is hepatic and is converted to inactive compounds

Dubotamine reduces high pressure due to ventricular filling (reduces preload) and facilitates ventricular atrial node conduction

Improves renal blood flow and urination.

Dobutamine | Miozac

Dubotamine is an injectable medicine used as an inotropic drug to control bradycardia in myocardial infarction, heart surgery, myocardial injury, septic shock and cardiogenic. It is also used in some cases to prevent and treat acute hypotension.

Mechanism of action of dobutamine:

Debutamine has a direct inotropic effect. By directly stimulating beta-one-heart receptors, it increases the contractile strength and stroke volume of the heart muscle, thereby increasing cardiac output. Dubotamine reduces the high pressure caused by ventricular filling (reduces preload) and facilitates the conduction of the ventricular atrial node. Increased cardiac output due to this drug, in addition to its dopaminergic effects, improves renal blood flow and urinary excretion.

Pharmacokinetics of dobutamine:

The metabolism of this medicine is hepatic and is converted to inactive compounds. The half-life of the medicine is about 2 minutes and its effect begins after 1-2 minutes. If the infusion rate is slow, the onset time may increase to 10 minutes. The duration of action of the medicine is less than 5 minutes and its excretion is mainly through the kidneys and as a metabolite.

Other Products

×

شما با تیم پشتیبانی آنلاین سینا پیشگام دارو نوین در حال تماس هستید

×